ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q2SCImago #10,353Hybrid

Brachytherapy

Acronym:brachyjournal
•
Abbreviation (ISO):BRACHYTHERAPY
•
Identifier (ISSN):1538-4721(Print)/1873-1449(Online)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
1.7↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2019–2026)

Clarivate IF trend for Brachytherapy

WoS Q4
12342.2320192.0320202.3620212.4420221.920231.720241.820251.72026
Annual Impact Factor Metric
Current (2026):1.7
Scopus SJR & RankScopus Q2
0.572
#10,353

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
62

62 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate23.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
151articles/year
10.49% Gold OA•94.12% Original Research

Aims & Scope

Brachytherapy is an international and multidisciplinary journal that publishes original peer-reviewed articles and selected reviews on the techniques and clinical applications of interstitial and intracavitary radiation in the management of cancers. Laboratory and experimental research relevant to clinical practice is also included. Related disciplines include medical physics, medical oncology, and radiation oncology and radiology. Brachytherapy publishes technical advances, original articles, reviews, and point/counterpoint on controversial issues. Original articles that address any aspect of brachytherapy are invited. Letters to the Editor-in-Chief are encouraged.

Topics Covered (Recognized by AI)
Medicine99.9%Internal medicine82.1%Surgery80.6%Radiology80.4%Radiation therapy73.6%Brachytherapy71%Biology62.6%Genetics57.1%Physics56.2%Cancer52.7%Medical physics46%Nuclear medicine42.6%Prostate cancer28.9%Oncology26.4%Prostate23.1%Chemistry22.1%Pathology21.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q4
Rank273/333
IndexSCIE
JCRSCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q3
Rank137/217
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank246/333
IndexSCIE
JCISCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q3
Rank145/217
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.7
Articles / Year77
Total Citations3
2025
IF1.8
Articles / Year264
Total Citations109
2024
IF1.7
Articles / Year371
Total Citations253
2023
IF1.9
Articles / Year338
Total Citations475
2022
IF2.441
Articles / Year292
Total Citations669

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,353Scopus Q2SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.572

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.62

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,064 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations517
3-Year Documents304
Citable Documents291

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Radiology, Nuclear Medicine and ImagingQ2
OncologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 23.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Brachytherapy (acronym: brachyjournal, abbr: BRACHYTHERAPY, ISSN: 1538-4721) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Inc. in United States since 2002. The periodical holds a Journal Impact Factor (JIF) of 1.70, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.572 (Q2), an H-index of 62.

The journal enforces rigorous peer evaluation with an average review speed of 9.1周, a publication frequency of Quarterly, an annual output of approximately 151 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,064 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Quarterly
Founding Year
2002
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c7382371-9e25-401d-a153-2175238e11a2
Database Updated: 2026-10-16